AIM2 and Parkinson disease: Conversely, a separate study has shown that in the MPTP mouse model, microglial AIM2 exerts a negative regulatory effect on neuroinflammation independent of the inflammasome, and its deficiency exacerbates symptoms in both MPTP-induced and transgenic PD mouse models (25).